Contrasting Envoy Medical (NASDAQ:COCH) and Inogen (NASDAQ:INGN)

Envoy Medical (NASDAQ:COCH) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

Institutional & Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 0.7% of Envoy Medical shares are held by insiders. Comparatively, 0.6% of Inogen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

Envoy Medical has a beta of 2.68, suggesting that its share price is 168% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500.

Profitability

This table compares Envoy Medical and Inogen’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	N/A	N/A	-100.39%
Inogen	-32.46%	-38.98%	-27.03%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Envoy Medical and Inogen, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Inogen	1	2	1	0	2.00

Envoy Medical currently has a consensus target price of $6.00, indicating a potential upside of 19.05%. Inogen has a consensus target price of $7.50, indicating a potential upside of 11.94%. Given Envoy Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Envoy Medical is more favorable than Inogen.

Valuation & Earnings

This table compares Envoy Medical and Inogen’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$320,000.00	308.70	-$29.91 million	N/A	N/A
Inogen	$315.66 million	0.50	-$102.45 million	($4.41)	-1.52

Envoy Medical has higher earnings, but lower revenue than Inogen.

Summary

Envoy Medical beats Inogen on 9 of the 12 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.